Labeler
Hikma Pharmaceuticals USA Inc. NDC Codes
Hikma Pharmaceuticals USA Inc. lists 752 finished drug products in the FDA NDC Directory under NDC labeler codes 0054, 0143, 0641, 24201.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Tapentadol, Ropivacaine Hydrochloride, Tyzavan, Daptomycin, Deflazacort, Lithium Carbonate, Eltrombopag, Cefepime Hydrochloride, Starjemza, Gemcitabine, Vancomycin Hydrochloride, dicyclomine hydrochloride, Meropenem, Atropine Sulfate, Fentanyl Citrate
- Active ingredients
- Tapentadol hydrochloride, Ropivacaine hydrochloride, Vancomycin, Daptomycin, Deflazacort, Lithium carbonate, Eltrombopag olamine, Cefepime hydrochloride, Ustekinumab, Gemcitabine hydrochloride, Vancomycin hydrochloride, Polymyxin b sulfate
- NDC labeler codes
- 0054, 0143, 0641, 24201
- Strengths (from the 100 most recently listed products)
- Daptomycin 500 mg/10mL; Ropivacaine hydrochloride 2 mg/mL; Gemcitabine hydrochloride 38 mg/mL; Daptomycin 350 mg/7mL; Lithium carbonate 300 mg/1; Tapentadol hydrochloride 100 mg/1; Tapentadol hydrochloride 50 mg/1; Ropivacaine hydrochloride 5 mg/mL; Cefepime hydrochloride 1 g/1; Cefepime hydrochloride 2 g/1; Ustekinumab 45 mg/.5mL; Fentanyl citrate 50 ug/mL; Glycopyrrolate .2 mg/mL; Mercaptopurine 20 mg/mL; Neomycin sulfate 3.5 mg/mL; Polymyxin b sulfate 10000 [iU]/mL; Hydrocortisone 10 mg/mL; Deflazacort 36 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1
- Dosage forms
- Injection, Injection, Solution, Injection, Powder, For solution, Tablet, Injection, Powder, Lyophilized, For solution, Tablet, Film coated, Extended release, Tablet, Film coated, Capsule, Capsule, Gelatin coated, Solution, Suspension, Solution/ drops, Liquid, Injection, Suspension
- Routes
- Intravenous, Oral, Intramuscular, Subcutaneous, Epidural, Infiltration, Perineural, Auricular (Otic), Intravascular, Intrathecal, Ophthalmic, Intra-articular
- Drug classes (FDA established)
- Opioid Agonist, Glycopeptide Antibacterial, Amide Local Anesthetic, Corticosteroid, Anticholinergic, Lipopeptide Antibacterial, Nucleoside Metabolic Inhibitor, Mood Stabilizer, Thrombopoietin Receptor Agonist, Cholinergic Muscarinic Antagonist, Cephalosporin Antibacterial, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Polymyxin-class Antibacterial, Penem Antibacterial, RANK Ligand Inhibitor, Serotonin-4 Receptor Agonist, Antiarrhythmic, Progesterone, Nondepolarizing Neuromuscular Blocker, Aminoglycoside Antibacterial, Cholinergic Receptor Agonist, Benzodiazepine, Catecholamine, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Janus Kinase Inhibitor, Antidote, Antidote for Acetaminophen Overdose, Mucolytic, Prostaglandin Analog, Central alpha-2 Adrenergic Agonist, Phenylalanine Hydroxylase Activator, Atypical Antipsychotic, beta-Adrenergic Blocker, Opioid Antagonist, Oxidation-Reduction Agent
- HCPCS / J-code
- J0171 — Injection, adrenalin, epinephrine, 0.1 mg, J0897 — Injection, denosumab, 1 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg
- Package NDCs
- 110 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Methotrexate | Methotrexate 1 g/1 | Injection, Powder, Lyophilized, For solutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | 0143-9367 | 00143-9367-01 | — |
| Fluconazole | Fluconazole 2 mg/mL | InjectionIntravenous | 0143-9899 | 00143-9899-91 | — |
| Buprenorphine Hydrochloride | Buprenorphine hydrochloride .324 mg/mL | InjectionIntramuscular, Intravenous | 0143-9246 | 00143-9246-05 | — |
| Octreotide Acetate | Octreotide acetate 200 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 0641-6177 | 00641-6177-01 | — |
| Octreotide Acetate | Octreotide acetate 1000 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 0641-6178 | 00641-6178-01 | — |
| Octreotide Acetate | Octreotide acetate 50 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 0641-6174 | 00641-6174-10 | — |
| Octreotide Acetate | Octreotide acetate 100 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 0641-6175 | 00641-6175-10 | — |
| Octreotide Acetate | Octreotide acetate 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 0641-6176 | 00641-6176-10 | — |
| Dexrazoxane | Dexrazoxane hydrochloride 250 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9247 | 00143-9247-01 | — |
| Dexrazoxane | Dexrazoxane hydrochloride 500 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9248 | 00143-9248-01 | — |
| Torsemide | Torsemide 20 mg/1 | TabletOral | 0054-0077 | 00054-0077-2500054-0077-29 | — |
| Lithium Carbonate | Lithium carbonate 300 mg/1 | Tablet, Extended releaseOral | 0054-0021 | 00054-0021-2500054-0021-29 | — |
| Cefazolin | Cefazolin sodium 10 g/1 | Injection, Powder, For solutionIntravenous | 0143-9261 | 00143-9261-10 | — |
| Cefazolin | Cefazolin sodium 10 g/1 | Injection, Powder, For solutionIntravenous | 0143-9983 | 00143-9983-03 | — |
| Cefazolin | Cefazolin sodium 20 g/1 | Injection, Powder, For solutionIntravenous | 0143-9665 | 00143-9665-10 | — |
| Allopurinol sodium | Allopurinol sodium 500 mg/25mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9533 | 00143-9533-01 | — |
| Digoxin | Digoxin .05 mg/mL | SolutionOral | 0054-0057 | 00054-0057-46 | — |
| Ketorolac Tromethamine | Ketorolac tromethamine 15 mg/mL | InjectionIntramuscular, Intravenous | 0641-6041 | 00641-6041-25 | — |
| Ketorolac Tromethamine | Ketorolac tromethamine 30 mg/mL | InjectionIntramuscular, Intravenous | 0641-6042 | 00641-6042-25 | — |
| Ketorolac Tromethamine | Ketorolac tromethamine 30 mg/mL | InjectionIntramuscular | 0641-6043 | 00641-6043-25 | — |
| Ciprofloxacin | Ciprofloxacin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 0143-9928 | 00143-9928-01 | — |
| Ciprofloxacin | Ciprofloxacin hydrochloride 750 mg/1 | Tablet, Film coatedOral | 0143-9929 | 00143-9929-50 | — |
| Citalopram | Citalopram hydrobromide 10 mg/5mL | SolutionOral | 0054-0062 | 00054-0062-58 | — |
| mesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | 0143-9260 | 00143-9260-01 | — |
| Mercaptopurine | Mercaptopurine 50 mg/1 | TabletOral | 0054-4581 | 00054-4581-1100054-4581-27 | — |
| Lithium Carbonate | Lithium carbonate 450 mg/1 | Tablet, Extended releaseOral | 0054-0020 | 00054-0020-25 | — |
| Cefuroxime | Cefuroxime sodium 750 mg/8mL | Injection, Powder, For solutionIntravenous | 0143-9976 | 00143-9976-03 | — |
| Cefuroxime | Cefuroxime sodium 1.5 g/1 | Injection, Powder, For solutionIntravenous | 0143-9977 | 00143-9977-22 | — |
| Cefuroxime | Cefuroxime sodium 750 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9979 | 00143-9979-22 | — |
| Cefuroxime | Cefuroxime sodium 1.5 g/1 | Injection, Powder, For solutionIntravenous | 0143-9567 | 00143-9567-25 | — |
| Cefuroxime | Cefuroxime sodium 750 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9568 | 00143-9568-25 | — |
| Cefuroxime | Cefuroxime sodium 7.5 g/1 | Injection, Powder, For solutionIntravenous | 0143-9569 | 00143-9569-10 | — |
| Ipratropium Bromide | Ipratropium bromide 21 ug/1 | SprayNasal | 0054-0045 | 00054-0045-44 | — |
| Ipratropium Bromide | Ipratropium bromide 42 ug/1 | SprayNasal | 0054-0046 | 00054-0046-41 | — |
| Calcitriol | Calcitriol 1 ug/mL | SolutionOral | 0054-3120 | 00054-3120-41 | — |
| Doxycycline Hyclate | Doxycycline hyclate 100 mg/1 | Tablet, CoatedOral | 0143-2112 | 00143-2112-0500143-2112-50 | — |
| Orphenadrine citrate | Orphenadrine citrate 60 mg/2mL | InjectionIntramuscular, Intravenous | 0641-6182 | 00641-6182-25 | — |
| PredniSONE | Prednisone 50 mg/1 | TabletOral | 0054-0019 | 00054-0019-2000054-0019-25 | — |
| PredniSONE | Prednisone 10 mg/1 | TabletOral | 0054-0017 | 00054-0017-2000054-0017-2500054-0017-29 | — |
| PredniSONE | Prednisone 20 mg/1 | TabletOral | 0054-0018 | 00054-0018-2000054-0018-2500054-0018-29 | — |
| Flecainide Acetate | Flecainide acetate 100 mg/1 | TabletOral | 0054-0011 | 00054-0011-2000054-0011-2100054-0011-25 | — |
| Flecainide Acetate | Flecainide acetate 150 mg/1 | TabletOral | 0054-0012 | 00054-0012-2000054-0012-2100054-0012-25 | — |
| Flecainide Acetate | Flecainide acetate 50 mg/1 | TabletOral | 0054-0010 | 00054-0010-2000054-0010-2100054-0010-25 | — |
| Cefotaxime | Cefotaxime sodium 2 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9933 | 00143-9933-25 | — |
| Cefotaxime | Cefotaxime sodium 10 g/1 | InjectionIntravenous | 0143-9935 | 00143-9935-01 | — |
| Cefotaxime | Cefotaxime sodium 500 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9930 | 00143-9930-10 | — |
| Cefotaxime | Cefotaxime sodium 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9931 | 00143-9931-25 | — |
| Midazolam Hydrochloride | Midazolam hydrochloride 2 mg/mL | SyrupOral | 0054-3566 | 00054-3566-99 | — |
| Butorphanol Tartrate | Butorphanol tartrate 10 mg/mL | Spray, MeteredNasal | 0054-3090 | 00054-3090-36 | — |
| Cefazolin | Cefazolin sodium 330 mg/mL | Injection, Powder, For solutionIntramuscular, Intravenous | 0143-9262 | 00143-9262-25 | — |
Hikma Pharmaceuticals USA Inc.: common questions
- What is Hikma Pharmaceuticals USA Inc.'s NDC labeler code?
- 0054, 0143, 0641, 24201. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Hikma Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J0171, J0897, J3357 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.